OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programming inactive RNA-binding small molecules into bioactive degraders
Yuquan Tong, Yeongju Lee, Xiaohui Liu, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 169-179
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Ultrasensitive DNA Origami Plasmon Sensor for Accurate Detection in Circulating Tumor DNAs
Zhi Chen, Changle Meng, Xueliang Wang, et al.
Laser & Photonics Review (2024) Vol. 18, Iss. 10
Closed Access | Times Cited: 50

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells
Fabian Offensperger, Gary Tin, Miquel Duran‐Frigola, et al.
Science (2024) Vol. 384, Iss. 6694
Closed Access | Times Cited: 22

Small and long non-coding RNAs: Past, present, and future
Ling‐Ling Chen, V. Narry Kim
Cell (2024) Vol. 187, Iss. 23, pp. 6451-6485
Closed Access | Times Cited: 12

A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation
Yangyang Huang, Xujiao Zhou, Yirou Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 8

Identification of RNA structures and their roles in RNA functions
Xinang Cao, Yueying Zhang, Yiliang Ding, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 10, pp. 784-801
Closed Access | Times Cited: 8

RNA–Small-Molecule Interaction: Challenging the “Undruggable” Tag
Jaskirat Kaur, Akanksha Sharma, Poonam Mundlia, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4259-4297
Closed Access | Times Cited: 6

Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera
Yuan‐Qin Min, Wei Xiong, Wei Shen, et al.
Science Advances (2024) Vol. 10, Iss. 15
Open Access | Times Cited: 6

Designing small molecules that target a cryptic RNA binding site via base displacement
Robert Batey, Lukasz T. Olenginski, Aleksandra J. Wierzba, et al.
Research Square (Research Square) (2025)
Closed Access

Stimulus-activated ribonuclease targeting chimeras for tumor microenvironment activated cancer therapy
Yuqi Zhang, Jinfeng Zhu, Ling Qiu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Small Molecules Targeting Viral RNA
Gregory Mathez, Valeria Cagno
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13500-13500
Open Access | Times Cited: 14

G-Quadruplex mRNAs Silencing with Inducible Ribonuclease Targeting Chimera for Precision Tumor Therapy
Yuan Zhang, Lingyan Wang, Fenglin Wang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 23, pp. 15815-15824
Closed Access | Times Cited: 5

RNATACs: Multispecific small molecules targeting RNA by induced proximity
Yan Song, Jia Cui, Jiaqiang Zhu, et al.
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1101-1117
Open Access | Times Cited: 5

Targeting MicroRNAs with Small Molecules
Kisanet Tadesse, Raphael I. Benhamou
Non-Coding RNA (2024) Vol. 10, Iss. 2, pp. 17-17
Open Access | Times Cited: 4

Recent advances in the molecular design and applications of viral RNA-targeting antiviral modalities
Jiaojiao Dai, Xiangyi Jiang, Edeildo Ferreira da Silva‐Júnior, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104074-104074
Closed Access | Times Cited: 4

Small molecule inhibition of RNA binding proteins in haematologic cancer
Amit Jaiswal, Michelle L. Thaxton, Georgia Scherer, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-14
Open Access | Times Cited: 3

Heterobifunctional small molecules to modulate RNA function
Sandra Kovachka, Yuquan Tong, Jessica L. Childs‐Disney, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 449-463
Closed Access | Times Cited: 3

Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 3

TAC‐tics for Leveraging Proximity Biology in Drug Discovery
Dhanusha A. Nalawansha, Kyle Mangano, Willem den Besten, et al.
ChemBioChem (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 9

Small molecules modulating RNA splicing: a review of targets and future perspectives
Léa Bouton, Agathe Ecoutin, Florian Malard, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1109-1126
Closed Access | Times Cited: 2

Antisense RNA C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms a triplex-like structure and binds small synthetic ligand
Leszek Błaszczyk, Marcin Ryczek, Bimolendu Das, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 11, pp. 6707-6717
Open Access | Times Cited: 2

Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
Yuan Fang, Qiuyue Wu, Feiyu Wang, et al.
Small Methods (2024)
Closed Access | Times Cited: 2

Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy
Ancuța Jurj, Beatrice Fontana, Gabriele Varani, et al.
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 809-824
Closed Access | Times Cited: 2

Protein isoform-centric therapeutics: expanding targets and increasing specificity
Peter Kjer-Hansen, Tri Giang Phan, Robert J. Weatheritt
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 759-779
Closed Access | Times Cited: 2

Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines
Yan‐Dong Tang, Changqing Yu, Xuehui Cai
Trends in Microbiology (2023) Vol. 32, Iss. 3, pp. 292-301
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top